Synopsis
Synopsis
0
VMF
0
Australia
0
South Africa
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Gtpl7055
2. Q420394
3. [({[(2s,3r,4s,5r,6r)-4,5-bis({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)-6-[({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)methyl]-2-{[(2r,3s,4s,5r)-3,4,5-tris({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)-2-[({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)methyl]oxolan-2-yl]oxy}oxan-3-yl]oxy}sulfonyl)oxy]alumanediol
Molecular Weight | 1464.8 g/mol |
---|---|
Molecular Formula | C11H44Al8O51S8 |
Hydrogen Bond Donor Count | 16 |
Hydrogen Bond Acceptor Count | 51 |
Rotatable Bond Count | 36 |
Exact Mass | 1463.713824 g/mol |
Monoisotopic Mass | 1463.713824 g/mol |
Topological Polar Surface Area | 532 Ų |
Heavy Atom Count | 78 |
Formal Charge | 0 |
Complexity | 2400 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 17 |
1 of 2 | |
---|---|
Drug Name | Carafate |
PubMed Health | Sucralfate (By mouth) |
Drug Classes | Antiulcer, Protectant |
Drug Label | CARAFATE Suspension contains sucralfate and sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex.CARAFATE Suspension for oral administration contains 1 g of sucralfate per 10 mL.CARAFATE Sus... |
Active Ingredient | Sucralfate |
Dosage Form | Tablet; Suspension |
Route | Oral |
Strength | 1gm/10ml; 1gm |
Market Status | Prescription |
Company | Forest Labs |
2 of 2 | |
---|---|
Drug Name | Carafate |
PubMed Health | Sucralfate (By mouth) |
Drug Classes | Antiulcer, Protectant |
Drug Label | CARAFATE Suspension contains sucralfate and sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex.CARAFATE Suspension for oral administration contains 1 g of sucralfate per 10 mL.CARAFATE Sus... |
Active Ingredient | Sucralfate |
Dosage Form | Tablet; Suspension |
Route | Oral |
Strength | 1gm/10ml; 1gm |
Market Status | Prescription |
Company | Forest Labs |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-04-18
Pay. Date : 2014-04-09
DMF Number : 16589
Submission : 2003-05-13
Status : Active
Type : II
NDC Package Code : 55512-0002
Start Marketing Date : 2009-07-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-04-08
Pay. Date : 2019-01-24
DMF Number : 33479
Submission : 2019-01-25
Status : Active
Type : II
Date of Issue : 2023-12-28
Valid Till : 2026-12-28
Written Confirmation Number : WC-0310
Address of the Firm :
NDC Package Code : 66039-946
Start Marketing Date : 2019-01-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3542
Submission : 1979-06-12
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-08-05
Pay. Date : 2024-07-03
DMF Number : 40145
Submission : 2024-07-04
Status : Active
Type : II
NDC Package Code : 54469-0009
Start Marketing Date : 2023-09-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-07-05
Pay. Date : 2015-12-18
DMF Number : 30056
Submission : 2016-02-03
Status : Active
Type : II
Certificate Number : R0-CEP 2019-185 - Rev 01
Issue Date : 2023-08-18
Type : Chemical
Substance Number : 1796
Status : Valid
NDC Package Code : 69984-001
Start Marketing Date : 2016-01-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2019-04-22
Registration Number : 20190211-211-J-310(2)
Manufacturer Name : Zhejiang Haisen Pharmaceutical Co., Ltd
Manufacturer Address : Xiangtan Village, Liushi Street, Dongyang City, Zhejiang Province, China.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5825
Submission : 1985-05-14
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11876
Submission : 1996-02-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7552
Submission : 1988-06-21
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6108
Submission : 1985-10-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3542
Submission : 1979-06-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7282
Submission : 1988-01-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6048
Submission : 1985-09-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7160
Submission : 1987-09-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7552
Submission : 1988-06-21
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5825
Submission : 1985-05-14
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6331
Submission : 1985-10-25
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6057
Submission : 1985-09-05
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7186
Submission : 1987-11-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : R0-CEP 2019-185 - Rev 01
Status : Valid
Issue Date : 2023-08-18
Type : Chemical
Substance Number : 1796
Japanese Pharmacopoeia Sucralfate Hydrate
Registration Number : 218MF10954
Registrant's Address : 5850-1 Higashine-ko, Higashine City, Yamagata Prefecture
Initial Date of Registration : 2006-11-24
Latest Date of Registration : 2006-11-24
Date of Issue : 2023-12-28
Valid Till : 2026-12-28
Written Confirmation Number : WC-0310
Address of the Firm : Plot No. Z-103/l, Dahej SEZ, Phase ll, Dahej, Dist-Bharuch, Gujarat
Registrant Name : Korea Pavise Pharmaceutical Co., Ltd.
Registration Date : 2019-06-25
Registration Number : 20190625-211-J-370
Manufacturer Name : Elementis Pharma GmbH
Manufacturer Address : Giulinistr. 2 67065 Ludwigshafen Germany
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2019-04-22
Registration Number : 20190211-211-J-310(2)
Manufacturer Name : Zhejiang Haisen Pharmaceutic...
Manufacturer Address : Xiangtan Village, Liushi Street, Dongyang City, Zhejiang Province, China.
Registrant Name : Intro Biopharma Co., Ltd.
Registration Date : 2019-04-03
Registration Number : 20190211-211-J-310(1)
Manufacturer Name : Zhejiang Haisen Pharmaceutic...
Manufacturer Address : Xiangtan Village, Liushi Street, Dongyang City, Zhejiang Province, China.
Registrant Name : Sechang International Co., Ltd.
Registration Date : 2019-02-11
Registration Number : 20190211-211-J-310
Manufacturer Name : Zhejiang Haisen Pharmaceutic...
Manufacturer Address : Xiangtan Village, Liushi Street, Dongyang City, Zhejiang Province, China.
NDC Package Code : 55512-0002
Start Marketing Date : 2009-07-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55512-0019
Start Marketing Date : 2012-09-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55603-215
Start Marketing Date : 2010-09-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0039
Start Marketing Date : 1998-04-01
End Marketing Date : 2026-03-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 66039-946
Start Marketing Date : 2019-01-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60592-709
Start Marketing Date : 2019-12-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0318
Start Marketing Date : 2012-04-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84142-001
Start Marketing Date : 2019-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-7401
Start Marketing Date : 1998-06-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54469-0010
Start Marketing Date : 2023-11-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
About the Company : We provide quality products and services, consistently, reliably responsibly and continuously applying some of the world’s most difficult to handle chemical technologies. Synth...
About the Company : Arudavis Labs is in the business of manufacturing and trading of Active Pharmaceutical Ingredients and Formulations. We have been serving the Pharmaceutical and Biotechnology Indus...
About the Company : HENGDIAN GROUP was established in 1975, till now it has become a transnational,conglomerate group and been one of the largest private-owned enterprises in China. The Pharmaceutical...
About the Company : Nitika Pharmaceutical Specialities was found in 1991 as a small manufacturing unit has grown today into a dynamic production center for a range of products finding applications in ...
About the Company : Northeast Pharmaceutical Group Co., Ltd ( NEPG ) is a large-scale comprehensive pharmaceutical enterprise in China.It is composed of three major business segments, i.e. 1. chemical...
About the Company : Northeast Pharmaceutical Group Co., Ltd ( NEPG ) is a large-scale comprehensive pharmaceutical enterprise in China.It is composed of three major business segments, i.e. 1. chemical...
About the Company : QINGDAO QINGMEI BIOTECH(hereinafter referred to as Qingmei) is a specialized pharmaceutical company founded by DAYON INTERNATIONAL HOLDING LIMITED, which is to expand international...
About the Company : Established in 2002, Tecoland represents selected cGMP manufacturers with proven capabilities in organic synthesis, fermentation production as well as process and method developmen...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Carafate-generic (sucralfate) is a USFDA approved pepsin A inhibitor small molecule drug candidate, which is indicated for the treatment of active duodenal ulcer.
Lead Product(s): Sucralfate
Therapeutic Area: Gastroenterology Brand Name: Carafate-Generic
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 23, 2024
Lead Product(s) : Sucralfate
Therapeutic Area : Gastroenterology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10 mL
Details : Carafate-generic (sucralfate) is a USFDA approved pepsin A inhibitor small molecule drug candidate, which is indicated for the treatment of active duodenal ulcer.
Brand Name : Carafate-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
May 23, 2024
Details:
The approval of Sucralfate Oral Suspension, through initial development of twelve different bioassays that tracked product's postulated clinical interactions using in vitro biology, marks a paradigm shift in how complex generic drug products can be commercialized.
Lead Product(s): Sucralfate
Therapeutic Area: Gastroenterology Brand Name: Sucralfate-Generic
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Vista Pharm
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 07, 2022
Lead Product(s) : Sucralfate
Therapeutic Area : Gastroenterology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Vista Pharm
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : The approval of Sucralfate Oral Suspension, through initial development of twelve different bioassays that tracked product's postulated clinical interactions using in vitro biology, marks a paradigm shift in how complex generic drug products can be comme...
Brand Name : Sucralfate-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
April 07, 2022
Regulatory Info : Generic
Registration Country : Bahrain
Brand Name : Sufad
Dosage Form : SUSPENSION
Dosage Strength : 1G/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Bahrain
Packaging :
Regulatory Info : Generic
Dosage : SUSPENSION
Dosage Strength : 1G/5ML
Brand Name : Sufad
Approval Date :
Application Number :
Registration Country : Bahrain
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Gel
Dosage Strength : 1G/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging :
Regulatory Info :
Dosage : Gel
Dosage Strength : 1G/5ML
Brand Name :
Approval Date :
Application Number :
Registration Country : China
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : SUCRAMED
Dosage Form : SUSPENSION
Dosage Strength : 1G
Packaging : 20S
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 20S
Regulatory Info : Generic
Dosage : SUSPENSION
Dosage Strength : 1G
Brand Name : SUCRAMED
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info :
Registration Country : South Korea
Ranitidine Hydrochloride; Bismuth; Sucralfate
Brand Name : Almiso Tablet
Dosage Form : Tablet
Dosage Strength : 84MG; 100MG; 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Packaging :
Regulatory Info :
Ranitidine Hydrochloride; Bismuth; Sucralfate
Dosage : Tablet
Dosage Strength : 84MG; 100MG; 300MG
Brand Name : Almiso Tablet
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info :
Registration Country : Indonesia
Brand Name : Peptovell
Dosage Form : Suspension
Dosage Strength : 500mg/5ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Indonesia
Packaging :
Regulatory Info :
Dosage : Suspension
Dosage Strength : 500mg/5ml
Brand Name : Peptovell
Approval Date :
Application Number :
Registration Country : Indonesia
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Suspension
Dosage Strength : 1G/5ML
Packaging : 100 ml Amber PET Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 100 ml Amber PET Bottle
Regulatory Info :
Dosage : Suspension
Dosage Strength : 1G/5ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : Mexico
Brand Name : Ulivotina
Dosage Form : Tablet
Dosage Strength : 1GM
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Mexico
Packaging : Bottle
Regulatory Info :
Dosage : Tablet
Dosage Strength : 1GM
Brand Name : Ulivotina
Approval Date :
Application Number :
Registration Country : Mexico
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 1000mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 1000mg
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Suspension
Dosage Strength : 1 GM ; 20 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Suspension
Dosage Strength : 1 GM ; 20 MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Glycerol Multi-Compendial
Application : Parenteral
Excipient Details : A & C's Glycerol multi-compendial is an excipient that meets USP-NF, EP and BP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Not Available
Ingredient(s) : Glycerol Excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Application : Parenteral
Excipient Details : A & C's Glycerol is an excipient which meets the USP monograph.
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?